US FDA Contracting Update: From Rating Site Quality Maturity To Blocking COVID-19 Scams

Contracts in works also would help track APIs, promote gene therapy standards, improve drug compounding, help extend shelf lives for US stockpile products and improve budget execution.

business
now the real work begins

The US Food and Drug Administration has been lining up contractors to help it with a variety of drug quality-related initiatives, most notably an ambitious effort to assess the quality management maturity of individual pharmaceutical manufacturing facilities.

The agency already has enlisted the help of St. Gallen University and Dun & Bradstreet for a survey-based study, while...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Manufacturing

More from Compliance